Aquarius Surgical Technologies (ASTI) AI Stock Analysis

• Market Cap: C$275.99K
• Dividend Yield: N/A
• Average Volume (3M): 8.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.65
• Revenue Growth: -57.16%
• EPS Growth: 2.93%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.03
• Shares Outstanding: 27,599,173
• 10 Day Avg. Volume: 11,100
• 30 Day Avg. Volume: 8,865
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.10
• Price to Sales (P/S): 6.05
• P/FCF Ratio: -1.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Aquarius Surgical Technologies faces significant financial challenges, with declining revenues, persistent losses, and liquidity issues being the most impactful factors. The technical analysis indicates weak momentum, and the valuation is unattractive due to a negative P/E ratio and no dividend yield. These factors combine to result in a low overall stock score.

Aquarius Surgical Technologies Business Overview & Revenue Model

Company Description

Aquarius Surgical Technologies, Inc. (ASTI) is a pioneering company in the medical device industry, specializing in the development and manufacture of innovative surgical instruments and technologies. With a focus on minimally invasive procedures, ASTI operates in various sectors including orthopedic, cardiovascular, and general surgery. The company is dedicated to enhancing surgical outcomes through advanced technology and precision engineering, offering a range of products such as robotic-assisted surgical systems, specialized surgical tools, and disposable medical devices.

How the Company Makes Money

ASTI generates revenue primarily through the sale of its surgical instruments and technologies to hospitals, surgical centers, and healthcare providers. Key revenue streams include direct sales of its robotic-assisted surgical systems, which often involve significant upfront costs, as well as recurring revenue from the sale of disposable components and accessories necessary for the operation of these systems. Additionally, ASTI may engage in partnerships with other medical technology companies and healthcare organizations to co-develop products or expand its market reach, further enhancing its revenue potential. Licensing agreements for proprietary technologies and participation in training and support programs for healthcare professionals also contribute to the company's earnings.

Aquarius Surgical Technologies Financial Statement Overview

Summary

Aquarius Surgical Technologies is facing significant financial challenges across all verticals. The income statement shows declining revenues and persistent losses, while the balance sheet reflects high leverage and negative equity. The cash flow statement indicates liquidity issues with negative cash flows. The company needs to address its operational inefficiencies and improve its financial stability to enhance its financial health.

Income Statement

Aquarius Surgical Technologies has experienced declining revenues with a negative revenue growth rate of -17.1% in the most recent year. The company also shows negative profit margins, with a net profit margin of -12.8%, indicating significant losses. The EBIT and EBITDA margins are also negative, reflecting operational inefficiencies. Overall, the income statement reveals financial struggles with declining revenues and persistent losses.

Balance Sheet

The balance sheet shows a concerning financial position with negative stockholders' equity, resulting in a negative debt-to-equity ratio. This indicates that liabilities exceed assets, posing a risk to financial stability. The return on equity is positive, but this is due to the negative equity base rather than profitability. Overall, the balance sheet reflects high leverage and financial instability.

Cash Flow

The cash flow statement shows negative operating and free cash flows, indicating cash outflows from operations. The free cash flow to net income ratio is 1.0, suggesting that cash flows are aligned with net losses. However, the negative operating cash flow coverage ratio highlights challenges in covering operational expenses. Overall, the cash flow statement reflects liquidity challenges and insufficient cash generation.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2021	Dec 2021
Income Statement
Total Revenue	84.32K	91.20K	203.73K	205.25K	583.44K	327.66K
Gross Profit	45.38K	47.31K	81.91K	132.85K	216.59K	130.30K
EBITDA	126.17K	-832.81K	-517.35K	-456.62K	-1.34M	-611.35K
Net Income	-233.66K	-1.17M	-723.44K	-757.66K	-1.81M	-859.20K
Balance Sheet
Total Assets	2.83M	1.95M	680.14K	574.44K	946.13K	894.98K
Cash, Cash Equivalents and Short-Term Investments	14.28K	7.56K	122.02K	107.38K	145.97K	158.19K
Total Debt	6.58M	6.47M	3.51M	4.04M	2.93M	3.24M
Total Liabilities	7.89M	7.72M	4.53M	5.18M	3.34M	4.11M
Stockholders Equity	-5.06M	-5.77M	-3.85M	-4.61M	-2.39M	-3.21M
Cash Flow
Free Cash Flow	-371.23K	-383.29K	38.82K	-256.92K	-509.00K	-117.38K
Operating Cash Flow	-371.23K	-383.29K	38.82K	-252.56K	-450.52K	-112.16K
Investing Cash Flow	-1.80M	-1.80M	0.00	-4.36K	-100.00K	-5.22K
Financing Cash Flow	2.07M	2.08M	-75.00K	242.29K	591.30K	129.59K

Aquarius Surgical Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.81 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ASTI.

Aquarius Surgical Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PINK	46 Neutral	C$29.10M	-0.90	-181.70%	―	209.29%	35.38%
THRM	45 Neutral	$3.12M	―	―	―	207.90%	-23.09%
ASTI	43 Neutral	C$275.99K	―	―	―	-57.16%	2.93%
ASG	40 Underperform	C$21.47M	―	-31.12%	―	9.71%	-118.02%
TLT	38 Underperform	C$53.98M	-12.00	-269.41%	―	1.46%	6.91%